Search

SEC Filing Madrigal Pharmaceuticals.

$ 13.00 · 4.9 (512) · In stock

SEC Filing Deciphera Pharmaceuticals, Inc.

Overview Madrigal Pharmaceuticals.

SEC Filing

SEC Filing Madrigal Pharmaceuticals.

Conshohocken-based Madrigal Pharmceuticals plans a $500M stock sale - Philadelphia Business Journal

g560783.jpg

Madrigal Pharmaceuticals: Odds Shortening On NASH Drug Approval (NASDAQ:MDGL)

ETFs Holding MDGL, Madrigal Pharmaceuticals Inc

SEC Filing

EDGAR Filing Documents for 0001193125-24-004269